Provided by Tiger Trade Technology Pte. Ltd.

Kiora Pharmaceuticals

2.15
+0.03001.42%
Post-market: 2.190.0400+1.86%19:54 EST
Volume:45.98K
Turnover:98.77K
Market Cap:7.91M
PE:-0.98
High:2.18
Open:2.13
Low:2.10
Close:2.12
52wk High:4.18
52wk Low:1.76
Shares:3.68M
Float Shares:3.39M
Volume Ratio:0.56
T/O Rate:1.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1900
EPS(LYR):0.8700
ROE:-32.58%
ROA:-17.07%
PB:0.35
PE(LYR):2.47

Loading ...

Nov 07, 2025

Major Issues Report

Form 8-K - Current report
Nov 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 18, 2025

Correspondence

Form CORRESP - Correspondence
Aug 13, 2025

Major Issues Report

Form 8-K - Current report
Aug 08, 2025

Major Issues Report

Form 8-K - Current report
Aug 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 21, 2025

Correspondence

Form CORRESP - Correspondence
Jun 04, 2025

Major Issues Report

Form 8-K - Current report
Jun 03, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2025

Major Issues Report

Form 8-K - Current report
Mar 25, 2025

Major Issues Report

Form 8-K - Current report
Mar 25, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 25, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 15, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]